Cancer Risk and Mortality Following Kaposi Sarcoma Among People with HIV in the United States, 2000 to 2019.

Sally Peprah, Eric A Engels, Qianlai Luo, Analise Monterosso, Colby H Cohen, Ruth M Pfeiffer, Meredith S Shiels

Abstract read

In one paragraph

Article in Cancer causes & control : CCC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sally PeprahDivision of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, RM 6-E218, Bethesda, MD, 20892, USA.

Eric A EngelsDivision of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, RM 6-E218, Bethesda, MD, 20892, USA.

Qianlai LuoDivision of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, RM 6-E218, Bethesda, MD, 20892, USA.

Analise MonterossoTexas Department of State Health Services, Austin, TX, USA.

Colby H CohenFlorida Department of Health, Tallahassee, FL, USA.

Ruth M PfeifferDivision of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, RM 6-E218, Bethesda, MD, 20892, USA.

Meredith S ShielsDivision of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, RM 6-E218, Bethesda, MD, 20892, USA. shielsms@mail.nih.gov.

Funding

NCCDPHP CDC HHS U01 DP006302NCCDPHP CDC HHS U58 DP003875NCCDPHP CDC HHS U58 DP003931NCHHSTP CDC HHS U62 PS001005NCHHSTP CDC HHS U62 PS003960NCHHSTP CDC HHS U62 PS004001NCHHSTP CDC HHS U62 PS004011NCI NIH HHS HHSN261201300019CNCI NIH HHS HHSN261201300019INCI NIH HHS HHSN261201300021CNCI NIH HHS HHSN261201800007CNCI NIH HHS HHSN261201800009CNCI NIH HHS HHSN261201800009I

6 · The paper itself

Abstract

People with HIV (PWH) have increased Kaposi sarcoma (KS) risk. Among 2,645 PWH with KS in the United States HIV/AIDS Cancer Match Study, subsequent cancer risk was elevated 2.8-fold (95% confidence interval [CI]: 2.4-3.3) compared to PWH without KS. Mortality after KS declined 2000-2002 and 2012-2015 (hazard ratio = 0.64; 95%CI: 0.55-0.74).

Indexed as

HIV InfectionsNeoplasmsSarcoma, KaposiAdultFemaleHumansMaleMiddle AgedRisk FactorsUnited StatesHIVKaposi sarcomaSurvival

Identifiers

PMID41546776

DOI10.1007/s10461-016-1644-y

PMCPMC12812070

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.